Monday, May 08, 2023 7:32:51 AM
Metabiogenix USA® is the officially licensed distributor of Metabiox® across the Western Hemisphere (North, South, and Central America), and Spain. Metabiox® was developed by the Japanese Medical Institute and is produced in Japan.
Metabiox® was certified in December 2021 by COFEPRIS (United Mexican States Federal Committee for Protection from Sanitary Risks), which is Mexico’s equivalent to the US Food & Drug Administration, as a new class of therapeutics. After 10 years of extensive research, several clinical trials in Japan and Mexico, Metabiox® has helped thousands of patients in Mexico:
Regulate cellular metabolism throughout the body (metabolic disease control)
Restore Metabolism and pancreatic function (pancreatic reset program)
Reverse Inflammation and markers of liver dysfunction
Reinforces intestinal motility, nutrient absorption, and immune system
Reset the sleep-wake cycle
About Japanese Medical Institute:
The Japanese Medical Institute was created to focus on bringing innovations to market leaders. The foundation of the company started on the discovery of the importance of gut microbiome synchronization with the interaction with the different microbiome axis in the body (brain, pancreas, liver, immune system, skin, and others) with the consequent potentiation in the management, control and in some cases remission of chronic degenerative diseases as well as life expectancy and maintenance of health in humans (Lifespan and Health span).
https://www.otcmarkets.com/stock/INQD/news/story?e&id=2520432
Recent INQD News
- Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend] • Edgar (US Regulatory) • 09/04/2024 06:49:54 PM
- Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend] • Edgar (US Regulatory) • 07/15/2024 09:22:21 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 12/01/2023 07:35:22 PM
Kona Gold Beverage, Inc. Updates Multi-Million Dollar Merger and Posts Over $1.2 Million in Q3 Revenues • KGKG • Nov 15, 2024 10:36 AM
HealthLynked Corp. Announces Third Quarter and Year-to-Date 2024 Results with Strategic Restructuring, Third-Party Debt Repayment, and Core Technology Focus • HLYK • Nov 15, 2024 8:00 AM
Alliance Creative Group (ACGX) Releases Q3 2024 Financial and Disclosure Report with an increase of over 100% in Net Income for 1st 9 months of 2024 vs 2023 • ACGX • Nov 14, 2024 8:30 AM
Unitronix Corp. Publishes Its Cryptocurrency Portfolio Strategy • UTRX • Nov 14, 2024 8:05 AM
Avant Technologies and Ainnova Tech Form Joint Venture to Advance Early Disease Detection Using Artificial Intelligence • AVAI • Nov 12, 2024 9:00 AM
Swifty Global Announces Launch of Swifty Sports IE, Expanding Sports Betting and Casino Services in the Irish Market • DRCR • Nov 12, 2024 9:00 AM